Wook-Jin Chung1, Ahryon Cho2, Kyunghee Byun3, Jeongsik Moon4, Xiaohu Ge5, Hye-Sun Seo6, Ejung Moon7, Rajesh Dash5, Phillip C Yang8. 1. Department of Cardiovascular Medicine, Stanford University, Stanford, CA, USA; Department of Cardiovascular Medicine, Gachon University, Incheon, Republic of Korea; Gachon Cardiovascular Research Institute, Gachon University, Incheon, Republic of Korea. 2. Department of Pathology, Stanford University, Stanford, CA, USA. 3. Gachon Cardiovascular Research Institute, Gachon University, Incheon, Republic of Korea; Department of Anatomy and Cell Biology, Gachon University, Incheon, Republic of Korea; Center for Genomics and Proteomics & Stem Cell Core Facility, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea. 4. Gachon Cardiovascular Research Institute, Gachon University, Incheon, Republic of Korea; Center for Genomics and Proteomics & Stem Cell Core Facility, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea. 5. Department of Cardiovascular Medicine, Stanford University, Stanford, CA, USA. 6. Division of Cardiology, Soon Chun Hyang University College of Medicine, Bucheon, Republic of Korea. 7. Department of Radiation Oncology, Stanford University, Stanford, CA, USA. 8. Department of Cardiovascular Medicine, Stanford University, Stanford, CA, USA. Electronic address: phillip@stanford.edu.
Abstract
BACKGROUND: Apelin-13 (A13) regulates cardiac homeostasis. However, the effects and mechanism of A13 infusion after an acute myocardial injury (AMI) have not been elucidated. This study assesses the restorative effects and mechanism of A13 on the peri-infarct region in murine AMI model. METHODS: 51 FVB/N mice (12weeks, 30g) underwent AMI. A week following injury, continuous micro-pump infusion of A13 (0.5μg/g/day) and saline was initiated for 4-week duration. Dual contrast MRI was conducted on weeks 1, 2, 3, and 5, consisting of delayed-enhanced and manganese-enhanced MRI. Four mice in each group were followed for an extended period of 4weeks without further infusion and underwent MRI scans on weeks 7 and 9. RESULTS: A13 infusion demonstrated preserved LVEF compared to saline from weeks 1 to 4 (21.9±3.2% to 23.1±1.7%* vs. 23.5±1.7% to 16.9±2.8%, *p=0.02), which persisted up to 9weeks post-MI (+1.4%* vs. -9.4%, *p=0.03). Mechanistically, dual contrast MRI demonstrated significant decrease in the peri-infarct and scar % volume in A13 group from weeks 1 to 4 (15.1 to 7.4% and 34.3 to 25.1%, p=0.02, respectively). This was corroborated by significant increase in 5-ethynyl-2'-deoxyuridine (EdU(+)) cells by A13 vs. saline groups in the peri-infarct region (16.5±3.1% vs. 8.1±1.6%; p=0.04), suggesting active cell mitosis. Finally, significantly enhanced mobilization of CD34(+) cells in the peripheral blood and up-regulation of APJ, fibrotic, and apoptotic genes in the peri-infarct region were found. CONCLUSIONS: A13 preserves cardiac performance by salvaging the peri-infarct region and may contribute to permanent restoration of the severely injured myocardium.
BACKGROUND:Apelin-13 (A13) regulates cardiac homeostasis. However, the effects and mechanism of A13 infusion after an acute myocardial injury (AMI) have not been elucidated. This study assesses the restorative effects and mechanism of A13 on the peri-infarct region in murineAMI model. METHODS: 51 FVB/N mice (12weeks, 30g) underwent AMI. A week following injury, continuous micro-pump infusion of A13 (0.5μg/g/day) and saline was initiated for 4-week duration. Dual contrast MRI was conducted on weeks 1, 2, 3, and 5, consisting of delayed-enhanced and manganese-enhanced MRI. Four mice in each group were followed for an extended period of 4weeks without further infusion and underwent MRI scans on weeks 7 and 9. RESULTS: A13 infusion demonstrated preserved LVEF compared to saline from weeks 1 to 4 (21.9±3.2% to 23.1±1.7%* vs. 23.5±1.7% to 16.9±2.8%, *p=0.02), which persisted up to 9weeks post-MI (+1.4%* vs. -9.4%, *p=0.03). Mechanistically, dual contrast MRI demonstrated significant decrease in the peri-infarct and scar % volume in A13 group from weeks 1 to 4 (15.1 to 7.4% and 34.3 to 25.1%, p=0.02, respectively). This was corroborated by significant increase in 5-ethynyl-2'-deoxyuridine (EdU(+)) cells by A13 vs. saline groups in the peri-infarct region (16.5±3.1% vs. 8.1±1.6%; p=0.04), suggesting active cell mitosis. Finally, significantly enhanced mobilization of CD34(+) cells in the peripheral blood and up-regulation of APJ, fibrotic, and apoptotic genes in the peri-infarct region were found. CONCLUSIONS: A13 preserves cardiac performance by salvaging the peri-infarct region and may contribute to permanent restoration of the severely injured myocardium.
Authors: Shahriar Heidary; Harendra Patel; Jaehoon Chung; Hajime Yokota; Sandeep N Gupta; Mihoko V Bennett; Chandra Katikireddy; Patricia Nguyen; John M Pauly; Masahiro Terashima; Michael V McConnell; Phillip C Yang Journal: J Am Coll Cardiol Date: 2010-06-15 Impact factor: 24.094
Authors: Saskia L M A Beeres; Frank M Bengel; Jozef Bartunek; Douwe E Atsma; Jonathan M Hill; Marc Vanderheyden; Martin Penicka; Martin J Schalij; William Wijns; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2007-03-06 Impact factor: 24.094
Authors: Georgina M Ellison; Daniele Torella; Santo Dellegrottaglie; Claudia Perez-Martinez; Armando Perez de Prado; Carla Vicinanza; Saranya Purushothaman; Valentina Galuppo; Claudio Iaconetti; Cheryl D Waring; Andrew Smith; Michele Torella; Carlos Cuellas Ramon; Jose Manuel Gonzalo-Orden; Valter Agosti; Ciro Indolfi; Manuel Galiñanes; Felipe Fernandez-Vazquez; Bernardo Nadal-Ginard Journal: J Am Coll Cardiol Date: 2011-06-30 Impact factor: 24.094
Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245
Authors: Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: István Szokodi; Pasi Tavi; Gábor Földes; Sari Voutilainen-Myllylä; Mika Ilves; Heikki Tokola; Sampsa Pikkarainen; Jarkko Piuhola; Jaana Rysä; Miklós Tóth; Heikki Ruskoaho Journal: Circ Res Date: 2002-09-06 Impact factor: 17.367
Authors: Samuel E Senyo; Matthew L Steinhauser; Christie L Pizzimenti; Vicky K Yang; Lei Cai; Mei Wang; Ting-Di Wu; Jean-Luc Guerquin-Kern; Claude P Lechene; Richard T Lee Journal: Nature Date: 2012-12-05 Impact factor: 49.962
Authors: Nur Hayati Jasmin; May Zaw Thin; Robert D Johnson; Laurence H Jackson; Thomas A Roberts; Anna L David; Mark F Lythgoe; Philip C Yang; Sean M Davidson; Patrizia Camelliti; Daniel J Stuckey Journal: Adv Sci (Weinh) Date: 2021-04-02 Impact factor: 17.521